Latest news
Third time lucky for Replimune as FDA OKs melanoma drug - pharmaphorumpharmaphorum · Fri, 07 Aug 2026 09:50:13 GMTFDA Finally OKs Twice-Rejected Melanoma Drug - MedPage TodayMedPage Today · Thu, 06 Aug 2026 21:40:02 GMTFDA OKs Lutetium Lu 177 Vipivotide Tetraxetan in Metastatic Prostate Cancer - CancerNetworkCancerNetwork · Fri, 31 Jul 2026 20:58:12 GMT